Connective Tissue Diseases  >>  AK106  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
AK106 / Asahi Kasei
NCT00902369 / 2008-006075-75: A Study of AK106-001616 in Patients With Rheumatoid Arthritis (RA)

Completed
2
130
Europe
AK106-001616, Placebo, Active comparator
Asahi Kasei Pharma Corporation
Rheumatoid Arthritis
10/09
07/10
NCT01285752 / 2010-021558-21: A Study of AK106-001616 in Patients With Rheumatoid Arthritis (RA)

Completed
2
240
Europe, RoW
AK106-001616, Active comparator
Asahi Kasei Pharma Corporation
Rheumatoid Arthritis
01/12
12/12

Download Options